论文部分内容阅读
该文报告CA19-9，CFA对55例胆道癌与52例胆道良性疾病的诊断价值，发现在胆道癌病人，其血清CA19－9的阳性率明显升高（P＜0．001）而CEA无明显变化（P＞0．05）。胆汁中CEA的阳性率明显升高（P＜0．01），CA19－9的阳性率在胆道良恶性疾病中均升高，无显著意义（P＞0．05）。认为血清CA19－9和胆汁CEA的含量测定，可为临床诊断胆道良恶性疾病提供一个较好的辅助诊断指标。
This article reports on the diagnostic value of CA19-9 and CFA in 55 cases of biliary tract cancer and 52 cases of benign biliary tract disease. It was found that in patients with biliary tract cancer, the positive rate of serum CA19-9 was significantly higher (P<0.001) and CEA was absent. Significant changes (P>0.05). The positive rate of CEA in bile was significantly higher (P<0.01), and the positive rate of CA19-9 was increased in benign and malignant biliary diseases, with no significant significance (P>0.05). It is considered that the determination of serum CA19-9 and bile CEA content can provide a good auxiliary diagnosis index for clinical diagnosis of benign and malignant biliary diseases.